HK IPOAI

TH MEDICAL-B

0269718AListed

醫療健康 · 广东真健康医疗科技开发股份有限公司是一家专注于医疗科技开发的生物技术公司。

TH MEDICAL-B (真健康醫療-B) (02697) is a listed Hong Kong IPO. This page brings together the offer price, entry fee, subscription timeline, grey-market context, allotment data and stage-based reference research in one place.

Offer price
HK$126.20
Final offer price
HK$126.20
One-lot win rate
2.0%

Predicted 3.6%

Proceeds
HK$449.9M
Public oversub.
1790.4x

Lot / entry fee 20 shares · HK$3K · Sponsor CICC / DBS Asia Capital

  1. Offer starts Jun 22
  2. /Offer closes Jun 25
  3. /Grey market Jun 29
  4. /Listing Jun 30Now

SubscriptionTH MEDICAL-B: subscription-stage reference

The subscription stage draws on the prospectus, sponsor record and early public filings. Allotment results and grey-market prints have not occurred yet.

Earlier stage
Reference rating
High attention
Reference score
78
Forecast grey range
+29.5% – +173.8%

Pre-greyTH MEDICAL-B: pre-grey-market reference

The pre-grey stage includes published allotment and public oversubscription data. Grey-market prints are not yet reflected here.

Earlier stage
Reference rating
High attention
Reference score
81.1
Forecast grey range
+28.7% – +172.2%

Post-greyTH MEDICAL-B: post-grey-market reference

The post-grey stage includes grey-market price and turnover observations. Listing-day results still follow official trading and company announcements.

Current
Reference rating
High attention
Reference score
84.1
Forecast first-day range
+166.2% – +238.7%
View factors and research
Model forecastListing-day trendStrong positiveUp probability 98.0%
Published outcome check
First-day resultBig up+217.0%Strong all day
Our call: Trend call valid
Covered 16/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heat
Offer size
Good quality
Cornerstone lockup
Post-lockup offer value
Recent same-rule trend
Strong trend
Recent same-type trend
Strong trend
Recent sector trend
Strong trend
Valuation
Average appeal
Fundamental quality
Weaker quality
Growth quality
High quality
Profitability
Weak quality
Cash runway
High quality
Customer concentration
Cornerstone quality
Sponsor record
Strong record
Greenshoe arrangementNo greenshoe
Stabilizer track record
A-share pre-grey trend
A-share listing-day trend
Public oversubscription
High heat
One-lot win rate
High heat
International placing
High heat
Final pricing position
Actual greenshoe use
Grey market return
Strong trend

The assessment and probability ranges are informational only and are not investment advice.

AI Research Report

Post-grey
The analysis report for this IPO is being generated.

Last updated 18:35:01

HK$349.80
+177.18%
Phillip grey
376.63238.0099.37HK$126.2016:1518:35
Listing price
HK$126.20
Open
High
Low
Bid / Ask
— / —
Volume
Turnover View source

TH MEDICAL-B: predicted allotment

Only key tiers are shown here. Full tiers and other allotment-pattern comparisons are on the allotment-odds page.

1 lot
3.6%

Predicted

Official
2.0%
A tail · Apply 1,500 lots
0.52 lots

Predicted

Official
0.57 lots
B head · Apply 2,000 lots
1.4 lots

Predicted

Official
1 lots
Top hammer
3.74 lots

Predicted

Official
2.44 lots
Most likely allotment patternLarger Pool A applications get less extra allotmentPool B allotment declines gradually with sizeView full allotment-odds research

How to read this page

These answers combine this IPO’s published figures with clearly labeled model estimates. They explain how to read the modules above and are not investment advice.

What is the one-lot allotment rate for TH MEDICAL-B?

Public allotment filings put the official one-lot rate at 2.0%, versus this site's pre-allotment model estimate of 3.6%. It is an observation for a 1-lot application, not a guaranteed result.

What is the difference between A-tail and B-head for TH MEDICAL-B?

Based on the prospectus's legal application tiers, A-tail is 1,500 lots and B-head is 2,000 lots, representing about HK$3.8M and HK$5.0M of application principal. Official average allotment was 0.57 lots and 1 lots, versus pre-allotment model estimates of 0.52 lots and 1.4 lots. Pool A and Pool B are allocated separately, so application size alone does not show capital efficiency.

Can the grey-market price of TH MEDICAL-B be treated as the listing price?

The compiled grey-market observation is about +177.2%, versus +217.0% on the listing day. Grey-market prints are pre-listing sentiment from public sources, not the official opening price.

Why does TH MEDICAL-B have three reference ratings?

The current status is "Listed", so start with the post-grey section. Subscription, pre-grey and post-grey each use only the public information available at that point, so the score can change. Labels are high attention / neutral / caution only — informational comparison, not a buy or subscribe call.